Gemtuzumab ozogamicin is efficacious in attaining complete remission in relapsed/refractory acute leukemia prior to hematopoietic cell transplant: A case series

Fatobene, Giancarlo; Souza, Gabriela Rodriguez de; Rodrigues, Celso Arrais; Novis, Yana Augusta Sarkis; Rocha, Vanderson.

Hematol., Transfus. Cell Ther. (Impr.); 43 (4), 2021

Publication year: 2021

Gemtuzumab/uso terapéutico, Trasplante de Células Madre Hematopoyéticas, Leucemia

Fulltext

More related